{
    "clinical_study": {
        "@rank": "164903", 
        "arm_group": [
            {
                "arm_group_label": "Conventional embryo culture", 
                "arm_group_type": "Active Comparator", 
                "description": "Conventional embryo culture in dishes, in droplets under oil."
            }, 
            {
                "arm_group_label": "Alternative embryo culture", 
                "arm_group_type": "Experimental", 
                "description": "Embryo culture in system using small enclosed containers"
            }
        ], 
        "brief_summary": {
            "textblock": "This study will compare two alternative embryo culture systems.  Embryos from each patient\n      will be randomly assigned to one of two systems.  One group will be cultured conventionally\n      in oil-covered droplets in dishes.  The other group will be assigned to an enclosed system."
        }, 
        "brief_title": "Comparison of Alternative Embryo Culture Systems", 
        "completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Infertility", 
        "condition_browse": {
            "mesh_term": "Infertility"
        }, 
        "detailed_description": {
            "textblock": "Qualifying and consenting IVF patients will have approximately half of their developing\n      embryos cultured in droplets covered with oil.  The other approximate half of their embryos\n      will be cultured in small enclosed containers.  Embryo assignments will be at random.\n      Regardless of culture system, all embryos will be cultured from the bipronuclear stage to\n      the blastocyst stage in the same (Global) media, without the usual refreshing of media on\n      day 3."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Female age 18 to 40, seeking IVF treatment\n\n          -  Ability to understand English (to obtain informed consent)\n\n          -  Use of an oocyte donor, sperm donor, gestational carrier, and/or genetic testing\n             (with blastocyst biopsy only) are allowed.\n\n        Exclusion Criteria:\n\n          -  Diminished ovarian reserve as evidenced by either elevated cycle day 3 follicle\n             stimulating hormone (FSH) level (\u226510 IU/L) or low antral follicle count (<8 antral\n             follicles)\n\n          -  Fewer than five (5) bipronuclear oocytes\n\n          -  Day 3 embryo biopsy for any reason\n\n          -  No minors may enroll"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "73", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 6, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02028897", 
            "org_study_id": "SAIRB-13-0040"
        }, 
        "intervention": [
            {
                "arm_group_label": "Conventional embryo culture", 
                "intervention_name": "Conventional embryo culture", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Alternative embryo culture", 
                "intervention_name": "Enclosed embryo culture", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "In vitro fertilization", 
            "IVF", 
            "Embryo culture", 
            "Blastocyst transfer"
        ], 
        "lastchanged_date": "January 7, 2014", 
        "location": {
            "contact": {
                "last_name": "Arlyn Garcia", 
                "phone": "702-254-1777"
            }, 
            "facility": {
                "address": {
                    "city": "Las Vegas", 
                    "country": "United States", 
                    "state": "Nevada", 
                    "zip": "89117"
                }, 
                "name": "Fertility Center of Las Vegas"
            }, 
            "investigator": [
                {
                    "last_name": "Bruce Shapiro, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Said Daneshmand, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparison of Alternative Embryo Culture Systems", 
        "overall_contact": {
            "last_name": "Arlyn Garcia", 
            "phone": "702-254-1777"
        }, 
        "overall_official": {
            "affiliation": "Fertility Center of Las Vegas", 
            "last_name": "Bruce Shapiro, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Proportion of cultured embryos that form blastocysts.", 
            "measure": "Blastulation rate", 
            "safety_issue": "No", 
            "time_frame": "5 days (sixth day of embryo development)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02028897"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Fertility Center of Las Vegas", 
            "investigator_full_name": "Bruce Shapiro M.D.", 
            "investigator_title": "Medical Director", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Inner cell mass size, number of trophectoderm cells, blastocyst diameter", 
                "measure": "Blastocyst morphology", 
                "safety_issue": "No", 
                "time_frame": "5 days (sixth day of development)"
            }, 
            {
                "description": "The result of the IVF cycle as no pregnancy, early pregnancy loss, or ongoing pregnancy at 10 weeks gestation (about 7 weeks post-transfer).", 
                "measure": "IVF outcome", 
                "safety_issue": "No", 
                "time_frame": "7 weeks post-transfer"
            }
        ], 
        "source": "Fertility Center of Las Vegas", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bruce Shapiro M.D.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}